Tag: Corporate

AB “Ignitis grupė” (hereinafter – the Group) informs that on the 1^st of August 2025 the Ministry of Finance of the Republic of Lithuania (hereinafter – the Ministry of Finance), which exercises the rights of the majority shareholder, announced the selection of three members from among civil servants to the Group’s Supervisory Board, in the areas of public policy and governance, regulatory, accounting and audit competences. Candidates may apply until the 21^st of August 2025 (inclusive).

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ: XELB), a leading media and consumer products company known for building socially driven, live-commerce-focused brands, today announced the pricing of its public offering of 2,181,818 shares of common stock at a public offering price of $1.10 per share. In a concurrent private placement, the Company also agreed to issue and sell an aggregate of 145,147 unregistered shares to certain insiders of the Company including the Company’s Chief Executive Officer, Robert D'Loren, at a purchase price of $1.36, which is equal to the closing price of the Company’s common stock on July 31, 2025. The closing of the offering is expected to occur on or about August 4, 2025, subject to the satisfaction of customary closing conditions.

WINNIPEG, Manitoba, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The North West Company Inc. (“North West”) is pleased to announce the appointment of Gregg Saretsky as a director of North West, effective today.

HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective August 1, 2025.

With over $4 billion in net assets, the Global X Uranium ETF is the world’s preeminent ETF providing investors broad exposure to companies involved in uranium mining and the production of nuclear components

Vast majority of patients dosed completed the full 12-week study